Cargando…

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis

Objective: Tumor hypoxia is a key factor in resistance to anti-cancer treatment. Herein, this study aimed to characterize hypoxia-related molecular subtypes and assess their correlations with immunotherapy and targeted therapy in clear cell renal cell carcinoma (ccRCC). Materials: We comprehensively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Weimin, Zhong, Hongbin, Zhang, Fengling, Huang, Chaoqun, Lin, Yao, Huang, Jiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267011/ https://www.ncbi.nlm.nih.gov/pubmed/34250018 http://dx.doi.org/10.3389/fmolb.2021.684050

Ejemplares similares

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC)
por: Zhong, Weimin, et al.
Publicado: (2021)

Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021)

Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology
por: Zhong, Weimin, et al.
Publicado: (2023)

Identification of 12 immune-related lncRNAs and molecular subtypes for the clear cell renal cell carcinoma based on RNA sequencing data
por: Zhong, Weimin, et al.
Publicado: (2020)

Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma
por: Liu, Hanxiang, et al.
Publicado: (2021)

Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma
por: Zhong, Weimin, et al.
Publicado: (2022)

Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents
por: Xiong, Zhenchong, et al.
Publicado: (2022)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
por: Song, Wenjing, et al.
Publicado: (2020)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Zheng, Bin, et al.
Publicado: (2021)

ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration
por: Tang, Yong-Fei, et al.
Publicado: (2023)

FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma
por: Zhao, Xuyang, et al.
Publicado: (2020)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
por: Wu, Zhulin, et al.
Publicado: (2020)

Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile
por: Shen, Tao, et al.
Publicado: (2022)

Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma
por: Sun, Si, et al.
Publicado: (2022)

Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
por: Bai, Jianrong, et al.
Publicado: (2022)

Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma
por: Chu, Guangdi, et al.
Publicado: (2021)

Analyzing and Validating the Prognostic Value of a TNF-Related Signature in Kidney Renal Clear Cell Carcinoma
por: Zhang, Wenhao, et al.
Publicado: (2021)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

The Role of TRPC6 in Renal Ischemia/Reperfusion and Cellular Hypoxia/Reoxygenation Injuries
por: Hou, Xin, et al.
Publicado: (2021)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma
por: Li, Changjiu, et al.
Publicado: (2021)

Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma
por: Lin, Gaoteng, et al.
Publicado: (2021)

Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma
por: Shen, Yuanhao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition
por: Sun, Guoliang, et al.
Publicado: (2021)

Silencing of the TRIM58 Gene by Aberrant Promoter Methylation is Associated with a Poor Patient Outcome and Promotes Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma
por: Gan, Ying, et al.
Publicado: (2021)

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
por: Zhang, Shiyu, et al.
Publicado: (2023)

Computational Methods for Single-Cell Imaging and Omics Data Integration
por: Watson, Ebony Rose, et al.
Publicado: (2022)

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy
por: Mo, Zhuomao, et al.
Publicado: (2020)

Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial–mesenchymal transition
por: Sun, Guoliang, et al.
Publicado: (2022)

Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity
por: Pan, Deshen, et al.
Publicado: (2021)

LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
por: Xiao, Junbo, et al.
Publicado: (2021)

Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma
por: Zhang, Guangyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f0qb5rarvq1udjgpcu1dt6s1nf